Cargando…

Long-Term Care Resident Awareness and Interest in Spasticity Treatments

Spasticity is common in long-term care settings (affecting up to one in three residents), yet it remains under-treated despite safe and effective, Food and Drug Administration (FDA)-approved therapies. One barrier to treatment may be lack of awareness of available therapies for long-term care reside...

Descripción completa

Detalles Bibliográficos
Autores principales: Hacker, Mallory L., Putman, Michael S., Gill, Chandler E., Turchan, Maxim, Hudson, Taylor S., Currie, Amanda D., Phibbs, Fenna T., Charles, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930982/
https://www.ncbi.nlm.nih.gov/pubmed/33802291
http://dx.doi.org/10.3390/geriatrics6010021
_version_ 1783660197692047360
author Hacker, Mallory L.
Putman, Michael S.
Gill, Chandler E.
Turchan, Maxim
Hudson, Taylor S.
Currie, Amanda D.
Phibbs, Fenna T.
Charles, David
author_facet Hacker, Mallory L.
Putman, Michael S.
Gill, Chandler E.
Turchan, Maxim
Hudson, Taylor S.
Currie, Amanda D.
Phibbs, Fenna T.
Charles, David
author_sort Hacker, Mallory L.
collection PubMed
description Spasticity is common in long-term care settings (affecting up to one in three residents), yet it remains under-treated despite safe and effective, Food and Drug Administration (FDA)-approved therapies. One barrier to treatment may be lack of awareness of available therapies for long-term care residents living with spasticity. A standardized spasticity treatment awareness and interest interview was conducted with 18 nursing home residents and 11 veterans’ home residents in this cross-sectional study. Veterans’ home residents were also asked about potential barriers to receiving spasticity treatment. Many residents across both long-term care facilities were unaware of most of the treatment options for spasticity. Participants were most aware of physical/occupational therapy (83%, 95% CI: 65–93%) and least aware of intrathecal baclofen (21%, 95% CI: 9–39%). After learning about treatments, only 7% of participants (95% CI: 0–23%) were not interested in receiving any form of spasticity treatment. Among residents previously unaware of spasticity treatments, at least one quarter became interested in receiving treatment and at least one-fifth indicated possibly being interested in the treatment after learning about it. Potential barriers to receiving treatment included traveling to see a doctor and limited knowledge of insurance coverage of spasticity treatments. These results suggest that patient-centered approaches, including education and discerning patient preferences, may improve spasticity treatment in long-term care settings.
format Online
Article
Text
id pubmed-7930982
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79309822021-03-05 Long-Term Care Resident Awareness and Interest in Spasticity Treatments Hacker, Mallory L. Putman, Michael S. Gill, Chandler E. Turchan, Maxim Hudson, Taylor S. Currie, Amanda D. Phibbs, Fenna T. Charles, David Geriatrics (Basel) Article Spasticity is common in long-term care settings (affecting up to one in three residents), yet it remains under-treated despite safe and effective, Food and Drug Administration (FDA)-approved therapies. One barrier to treatment may be lack of awareness of available therapies for long-term care residents living with spasticity. A standardized spasticity treatment awareness and interest interview was conducted with 18 nursing home residents and 11 veterans’ home residents in this cross-sectional study. Veterans’ home residents were also asked about potential barriers to receiving spasticity treatment. Many residents across both long-term care facilities were unaware of most of the treatment options for spasticity. Participants were most aware of physical/occupational therapy (83%, 95% CI: 65–93%) and least aware of intrathecal baclofen (21%, 95% CI: 9–39%). After learning about treatments, only 7% of participants (95% CI: 0–23%) were not interested in receiving any form of spasticity treatment. Among residents previously unaware of spasticity treatments, at least one quarter became interested in receiving treatment and at least one-fifth indicated possibly being interested in the treatment after learning about it. Potential barriers to receiving treatment included traveling to see a doctor and limited knowledge of insurance coverage of spasticity treatments. These results suggest that patient-centered approaches, including education and discerning patient preferences, may improve spasticity treatment in long-term care settings. MDPI 2021-03-03 /pmc/articles/PMC7930982/ /pubmed/33802291 http://dx.doi.org/10.3390/geriatrics6010021 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Hacker, Mallory L.
Putman, Michael S.
Gill, Chandler E.
Turchan, Maxim
Hudson, Taylor S.
Currie, Amanda D.
Phibbs, Fenna T.
Charles, David
Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title_full Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title_fullStr Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title_full_unstemmed Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title_short Long-Term Care Resident Awareness and Interest in Spasticity Treatments
title_sort long-term care resident awareness and interest in spasticity treatments
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930982/
https://www.ncbi.nlm.nih.gov/pubmed/33802291
http://dx.doi.org/10.3390/geriatrics6010021
work_keys_str_mv AT hackermalloryl longtermcareresidentawarenessandinterestinspasticitytreatments
AT putmanmichaels longtermcareresidentawarenessandinterestinspasticitytreatments
AT gillchandlere longtermcareresidentawarenessandinterestinspasticitytreatments
AT turchanmaxim longtermcareresidentawarenessandinterestinspasticitytreatments
AT hudsontaylors longtermcareresidentawarenessandinterestinspasticitytreatments
AT currieamandad longtermcareresidentawarenessandinterestinspasticitytreatments
AT phibbsfennat longtermcareresidentawarenessandinterestinspasticitytreatments
AT charlesdavid longtermcareresidentawarenessandinterestinspasticitytreatments